CN110051365A - A kind of implanted electrode for continuing to monitor for a long time - Google Patents
A kind of implanted electrode for continuing to monitor for a long time Download PDFInfo
- Publication number
- CN110051365A CN110051365A CN201910326629.8A CN201910326629A CN110051365A CN 110051365 A CN110051365 A CN 110051365A CN 201910326629 A CN201910326629 A CN 201910326629A CN 110051365 A CN110051365 A CN 110051365A
- Authority
- CN
- China
- Prior art keywords
- layer
- electrode
- long
- continuous monitoring
- term continuous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012544 monitoring process Methods 0.000 claims abstract description 27
- 230000007774 longterm Effects 0.000 claims abstract description 19
- 239000010410 layer Substances 0.000 claims description 52
- 239000000463 material Substances 0.000 claims description 19
- 239000002346 layers by function Substances 0.000 claims description 12
- 238000002955 isolation Methods 0.000 claims description 11
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 10
- 239000002861 polymer material Substances 0.000 claims description 8
- 229910000510 noble metal Inorganic materials 0.000 claims description 5
- 229910052697 platinum Inorganic materials 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 229920001002 functional polymer Polymers 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000010970 precious metal Substances 0.000 claims description 3
- 229920000557 Nafion® Polymers 0.000 claims description 2
- 229920002301 cellulose acetate Polymers 0.000 claims description 2
- 239000007809 chemical reaction catalyst Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000002082 metal nanoparticle Substances 0.000 claims description 2
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 claims description 2
- 229920000767 polyaniline Polymers 0.000 claims description 2
- 229920000128 polypyrrole Polymers 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 239000008204 material by function Substances 0.000 claims 1
- 239000011241 protective layer Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 238000002513 implantation Methods 0.000 abstract description 5
- 208000014674 injury Diseases 0.000 abstract description 2
- 230000008733 trauma Effects 0.000 abstract description 2
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 210000004207 dermis Anatomy 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000013461 design Methods 0.000 description 3
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 239000002659 electrodeposit Substances 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002052 molecular layer Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000009168 stem cell therapy Methods 0.000 description 1
- 238000009580 stem-cell therapy Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
本发明公开了一种用于长期持续监测的植入式电极,包括基底电极、传感腔、绝缘层、连接触点和刺入部。所述传感腔位于电极中部,两端由绝缘层包覆,形成两端高,中间低的结构,传感腔内部包括螺旋功能层、信号增强层、承载层、信号层和隔离层。本发明所提供的用于长期持续监测的植入式电极可徒手刺入人体真皮层,持续监测体液中血糖的变化。具有结构简单紧凑、监测时间长、操作方便、减轻植入创伤和避免传感膜层脱落等优点。
The invention discloses an implantable electrode for long-term continuous monitoring, comprising a base electrode, a sensing cavity, an insulating layer, a connection contact and a piercing part. The sensing cavity is located in the middle of the electrode, and both ends are covered by an insulating layer, forming a structure with high ends and a low middle. The implanted electrode for long-term continuous monitoring provided by the present invention can be inserted into the dermis layer of the human body with bare hands to continuously monitor the changes of blood sugar in the body fluid. It has the advantages of simple and compact structure, long monitoring time, convenient operation, alleviation of implantation trauma, and avoidance of the sensor film layer falling off.
Description
【技术领域】【Technical field】
本发明专利涉及医疗监测设备技术领域,特别涉及皮下持续性血糖监测微针电极。The patent of the present invention relates to the technical field of medical monitoring equipment, in particular to a microneedle electrode for subcutaneous continuous blood glucose monitoring.
【背景技术】【Background technique】
据国际糖尿病联盟(IDF)统计,目前全球糖尿病在20~79岁成人中的患病率为8.8%,预计到2040年将上升至10.4%。糖尿病蔓延速度之快,每年约有500万人死于糖尿病及其相关并发症,占全因死亡人数的14.5%,较2013年的8.39%有了显著增加。其中,我国以1.096亿患病人数位居全球首位,预计到2040年将增长至1.51亿,因糖尿病死亡的人数每年超100万。According to the International Diabetes Federation (IDF), the current global prevalence of diabetes among adults aged 20 to 79 is 8.8%, and it is expected to rise to 10.4% by 2040. Diabetes is spreading so fast that about 5 million people die each year from diabetes and its related complications, accounting for 14.5% of all-cause deaths, a significant increase from 8.39% in 2013. Among them, my country ranks first in the world with 109.6 million patients, and it is expected to increase to 151 million by 2040, and the number of deaths due to diabetes exceeds 1 million every year.
但调查发现,我国糖尿病患者的治疗率仅为25.8%,由于糖尿病的危害主要在于由其引起的各类并发症,因此,未能接受治疗的患者更易遭受到并发症的侵袭。且据中英科学家的最新研究显示,与无糖尿病者相比,我国成人糖尿病患者的平均寿命将缩短9年。However, the survey found that the treatment rate of diabetic patients in my country is only 25.8%. Since the harm of diabetes mainly lies in various complications caused by it, patients who fail to receive treatment are more likely to suffer from complications. And according to the latest research by Chinese and British scientists, compared with people without diabetes, the average life expectancy of Chinese adults with diabetes will be shortened by 9 years.
目前,对于糖尿病的治疗是通过生活方式干预、干细胞治疗以及个性化药物治疗等方法将患者的血糖水平维持在正常范围内以达到不同程度的缓解,尚未有可完全根治的方法。较传统的指血测量方法对血糖的控制效果较明显,但是因其不能预警和发现高低血糖,尤其是对身体损害巨大的夜间低血糖和无症状低血糖,治疗效果具有一定的局限性。动态血糖监测技术以能反映及预测血糖波动特征的优势,对于缓解糖尿病有重要意义。但是对于大多数患者而言,动态血糖监测产品多为进口,一个传感器仅能监测7天左右,无法实现长期监测,反复更换传感器会带来感染的风险和沉重的经济负担。At present, the treatment of diabetes is to maintain the blood sugar level of patients within the normal range through lifestyle intervention, stem cell therapy and personalized drug therapy to achieve different degrees of remission, and there is no complete cure. The more traditional finger blood measurement method has obvious effect on blood sugar control, but because it cannot warn and detect high and low blood sugar, especially for nocturnal hypoglycemia and asymptomatic hypoglycemia that damage the body, the therapeutic effect has certain limitations. Continuous blood glucose monitoring technology has the advantage of reflecting and predicting the characteristics of blood glucose fluctuations, which is of great significance for relieving diabetes. However, for most patients, CGM products are mostly imported, and a sensor can only monitor for about 7 days, which cannot achieve long-term monitoring. Repeated replacement of the sensor will bring the risk of infection and a heavy economic burden.
为此,本申请人设计了一种用于长期持续监测的植入式电极,电极通过设计空腔式螺旋传感部,旨在设计患者可轻松使用、长期监测的传感电极,提高患者的依从性,使血糖浓度长期维持稳定,远离高血糖及其并发症。To this end, the applicant has designed an implantable electrode for long-term continuous monitoring. The electrode is designed with a cavity-type spiral sensing part, aiming to design a sensing electrode that can be easily used by patients and monitored for a long time, so as to improve the patient's safety. Compliance, to maintain long-term stable blood sugar concentration, away from hyperglycemia and its complications.
【发明内容】[Content of the invention]
本发明专利针对上述现有技术存在的缺陷,设计了一种结构简单紧凑、可长时间监测、易于徒手操作、能减轻植入创伤的用于长期持续监测的植入式电极,有助于血糖紊乱患者实现自我监测,稳定控制血糖浓度。Aiming at the defects of the above-mentioned prior art, the patent of the present invention designs an implantable electrode for long-term continuous monitoring, which is simple and compact in structure, can be monitored for a long time, easy to operate with bare hands, and can reduce implantation trauma. Disorder patients realize self-monitoring and stable control of blood glucose concentration.
一种用于长期持续监测的植入式电极包括基底电极、传感腔、绝缘层、连接触点,刺入部;所述基底电极材料为刚性金属,形状为针型,直径在0.1~0.5mm之间,长度小于10cm;所述绝缘层材料为绝缘高分子材料,涂布在传感腔以外的区域;传感腔位于电极中部,两端由绝缘层包覆,形成两端高,中间低的结构,内部包括螺旋功能层、信号增强层、承载层、信号层、隔离层。An implantable electrode for long-term continuous monitoring includes a base electrode, a sensing cavity, an insulating layer, a connecting contact, and a piercing part; the base electrode material is rigid metal, the shape is needle-shaped, and the diameter is 0.1-0.5 mm, and the length is less than 10cm; the insulating layer material is an insulating polymer material, which is coated in the area outside the sensing cavity; the sensing cavity is located in the middle of the electrode, and the two ends are covered by an insulating layer, forming two ends high, the middle The low structure includes a spiral functional layer, a signal enhancement layer, a carrier layer, a signal layer, and an isolation layer.
螺旋功能层材料为贵金属修饰在基底电极上;信号增强层材料为贵金属纳米颗粒,修饰在螺旋功能层和基底电极上;承载层材料为功能性高分子材料;信号层材料为反应催化物中的任意一种或多种组合;隔离层材料为具有生物相容性的高分子材料的任意一种或多种组合;刺入部表面涂布绝缘层和隔离层。The material of the helical functional layer is a noble metal modified on the base electrode; the material of the signal enhancement layer is a noble metal nanoparticle, which is modified on the helical functional layer and the base electrode; the material of the carrier layer is a functional polymer material; the material of the signal layer is a reaction catalyst. Any one or more combinations; the isolation layer material is any one or more combinations of biocompatible polymer materials; the surface of the piercing portion is coated with an insulating layer and an isolation layer.
所述绝缘层涂布在除传感腔外的其它部分,厚度大于传感腔。The insulating layer is coated on other parts except the sensing cavity, and the thickness is larger than that of the sensing cavity.
所述螺旋功能层的材料为金、铂、铂铱等贵金属中的一种或多种组合。The material of the spiral functional layer is one or more combinations of precious metals such as gold, platinum, platinum-iridium, etc.
所述的承载层材料为功能性高分子材料,选用Nafion、醋酸纤维素、聚苯胺、聚吡咯、多元酚及其衍生物中的任意一种或多种组合。The bearing layer material is a functional polymer material, selected from any one or a combination of Nafion, cellulose acetate, polyaniline, polypyrrole, polyphenol and derivatives thereof.
所述的刺入部表面涂布绝缘层和隔离层,涂布时不改变尖端部的形状。The surface of the piercing portion is coated with an insulating layer and an isolation layer, and the shape of the tip portion is not changed during coating.
与现有技术相比。本发明的优点在于:compared to the existing technology. The advantages of the present invention are:
1.本发明的一种用于长期持续监测的植入式电极,通过选用刚性较强的材料作为基底电极,在患者使用的过程中,即可直接徒手植入,又能减轻植入过程中的创伤,减轻了患者的心理负担,提高了产品的依从性,进而推动了动态血糖监测产品在我国糖尿病患者中的使用。1. An implanted electrode for long-term continuous monitoring of the present invention, by selecting a material with strong rigidity as the base electrode, can be directly implanted with bare hands during the patient's use, and can reduce the need for implantation during the implantation process. It reduces the psychological burden of patients, improves product compliance, and promotes the use of continuous blood glucose monitoring products in diabetic patients in my country.
2.本发明的一种用于长期持续监测的植入式电极,通过采用极细贵金属丝缠绕基底电极构成螺旋型功能层一,与传统的针式电极相比,即可增加电极的体表面积比,从而增加固定葡萄糖氧化酶的数量,又可提高不锈钢的电学特性,进而提高电极的信噪比和准确度。2. An implantable electrode used for long-term continuous monitoring of the present invention uses a very fine precious metal wire to wrap the base electrode to form a helical functional layer 1. Compared with the traditional needle electrode, the body surface area of the electrode can be increased. ratio, thereby increasing the number of immobilized glucose oxidase, and improving the electrical properties of stainless steel, thereby improving the signal-to-noise ratio and accuracy of the electrode.
3.本发明的一种用于长期持续监测的植入式电极,通过采用绝缘层形成针式传感腔,在传感器监测过程中,可保护固定酶层,又可保持植入刚性的同时削减针尖的锐度,有效缓解因尖锐针尖植入后引发的强烈异物反应,进而提高了传感器的监测寿命。3. An implanted electrode used for long-term continuous monitoring of the present invention uses an insulating layer to form a needle-type sensing cavity. During the sensor monitoring process, the fixed enzyme layer can be protected, and the rigidity of the implant can be kept at the same time. The sharpness of the needle tip can effectively alleviate the strong foreign body reaction caused by the implantation of the sharp needle tip, thereby improving the monitoring life of the sensor.
【附图说明】【Description of drawings】
图1是用于长期持续监测的植入式电极传感器区域划分结构图Figure 1 is a structural diagram of the area division of the implantable electrode sensor for long-term continuous monitoring
图1中:In Figure 1:
1—基底电极、2—传感腔、3—绝缘层、4—连接触点、5—螺旋功能层、6—信号增强层、7—承载层、8—信号层、9—隔离层、10—刺入部。1—Substrate electrode, 2—Sensing cavity, 3—Insulation layer, 4—Connecting contacts, 5—Spiral functional layer, 6—Signal enhancement layer, 7—Bearing layer, 8—Signal layer, 9—Isolation layer, 10 - The piercing part.
【具体实施方式】【Detailed ways】
以下将结合说明书附图和具体实施例对本发明做进一步详细说明。The present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments.
如图1所示,一种用于长期持续监测的植入式电极包括:基底电极1、传感腔2、绝缘层3、连接触点4,刺入部10;所述传感腔2包括螺旋功能层5、信号增强层6、承载层7、信号层8、隔离层9。As shown in FIG. 1, an implantable electrode for long-term continuous monitoring includes: a base electrode 1, a sensing cavity 2, an insulating layer 3, a connecting contact 4, and a piercing portion 10; the sensing cavity 2 includes Spiral functional layer 5 , signal enhancement layer 6 , bearing layer 7 , signal layer 8 , isolation layer 9 .
基底电极1材料为刚性金属,形状为针型,直径在0.1~0.5mm之间,长度小于10cm;所绝缘层材料为绝缘高分子材料,涂布在传感腔2以外的区域;螺旋功能层5材料为贵金属修饰在基底电极1上;信号增强层6材料为贵金属纳米颗粒,修饰在螺旋功能层5和基底电极1上;承载层7材料为功能性高分子材料;信号层8材料为反应催化物中的任意一种或多种组合;隔离层9材料为具有生物相容性的高分子材料的任意一种或多种组合;刺入部10表面涂布绝缘层3和隔离层9。The material of the base electrode 1 is rigid metal, the shape is needle-shaped, the diameter is between 0.1 and 0.5 mm, and the length is less than 10 cm; the insulating layer material is insulating polymer material, which is coated on the area outside the sensing cavity 2; the spiral functional layer 5. The material is noble metal modified on the base electrode 1; Any one or more combinations of the catalysts; the material of the isolation layer 9 is any one or more combinations of biocompatible polymer materials;
其中,所述的铂纳米层通过电沉积的方式制备而得,选用不同浓度配比的电解液和沉积电位电沉积铂纳米颗粒,电解液浓度和电位对铂纳米颗粒直径大小、表面形态及其铂层致密性有重要影响。Wherein, the platinum nano-layer is prepared by electrodeposition. Electrolyte and deposition potential of different concentration ratios are used to electrodeposit platinum nanoparticles. The density of the platinum layer has an important effect.
所述的承载层,通过滴取不同的容量至传感腔,其中,滴取量影响膜层厚度进而影响体表面积比和活性位点。The bearing layer is dripped with different capacities into the sensing cavity, wherein the dripped amount affects the thickness of the film layer and thus affects the body surface area ratio and active sites.
通过控制信号增强层的分布和承载层的厚度,形成适应信号层中催化物质大小的孔径结构,从而提供更高的体表面积比以更稳定的方式固定过量的催化物,进而提高传感器的监测寿命,减轻患者因频繁更换传感器造成的恐惧心理和经济负担。By controlling the distribution of the signal enhancement layer and the thickness of the carrier layer, a pore structure adapted to the size of the catalytic species in the signal layer is formed, thereby providing a higher body surface area ratio and immobilizing the excess catalytic species in a more stable manner, thereby improving the monitoring life of the sensor. , to reduce the patient's fear and economic burden caused by frequent sensor replacement.
应说明的是,以上实施例仅用以说明本发明专利徒手植入式螺旋微针传感电极的说明,而不是对本发明专利的限定。本领域的普通技术人员应当理解,可以对本设计的技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围,其均应涵盖在本发明的权利要求范围当中。It should be noted that the above embodiments are only used to illustrate the description of the free-hand implantable spiral microneedle sensing electrode of the patent of the present invention, rather than a limitation of the patent of the present invention. It should be understood by those of ordinary skill in the art that the technical solutions of the present design can be modified or equivalently replaced without departing from the spirit and scope of the technical solutions of the present invention, which should be included in the scope of the claims of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910326629.8A CN110051365A (en) | 2019-04-23 | 2019-04-23 | A kind of implanted electrode for continuing to monitor for a long time |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910326629.8A CN110051365A (en) | 2019-04-23 | 2019-04-23 | A kind of implanted electrode for continuing to monitor for a long time |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110051365A true CN110051365A (en) | 2019-07-26 |
Family
ID=67320101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910326629.8A Pending CN110051365A (en) | 2019-04-23 | 2019-04-23 | A kind of implanted electrode for continuing to monitor for a long time |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110051365A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110881984A (en) * | 2019-11-20 | 2020-03-17 | 浙江大学 | Single-electrode implanted blood glucose sensor |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102920465A (en) * | 2012-10-26 | 2013-02-13 | 浙江大学 | Glucose sensor |
CN103328650A (en) * | 2011-01-20 | 2013-09-25 | 美敦力迷你迈德公司 | Layered enzyme compositions for use with analyte sensors |
CN103462615A (en) * | 2013-09-13 | 2013-12-25 | 上海移宇科技有限公司 | Micrometer-scale glucose sensor microelectrode |
CN104622480A (en) * | 2013-11-12 | 2015-05-20 | 上海移宇科技有限公司 | Single-needle integrated artificial pancreas |
US20170173216A1 (en) * | 2006-06-22 | 2017-06-22 | University Of South Florida | Collagen scaffolds, medical implants with same and methods of use |
CN109406589A (en) * | 2018-11-23 | 2019-03-01 | 浙江大学 | A kind of implanted blood sugar test probe and its production method based on silk-screen printing |
-
2019
- 2019-04-23 CN CN201910326629.8A patent/CN110051365A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170173216A1 (en) * | 2006-06-22 | 2017-06-22 | University Of South Florida | Collagen scaffolds, medical implants with same and methods of use |
CN103328650A (en) * | 2011-01-20 | 2013-09-25 | 美敦力迷你迈德公司 | Layered enzyme compositions for use with analyte sensors |
CN102920465A (en) * | 2012-10-26 | 2013-02-13 | 浙江大学 | Glucose sensor |
CN103462615A (en) * | 2013-09-13 | 2013-12-25 | 上海移宇科技有限公司 | Micrometer-scale glucose sensor microelectrode |
CN104622480A (en) * | 2013-11-12 | 2015-05-20 | 上海移宇科技有限公司 | Single-needle integrated artificial pancreas |
CN109406589A (en) * | 2018-11-23 | 2019-03-01 | 浙江大学 | A kind of implanted blood sugar test probe and its production method based on silk-screen printing |
Non-Patent Citations (1)
Title |
---|
潘帅等: "基于表面重建螺旋型铂铱电极的葡萄糖生物传感器", 《高等学校化学学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110881984A (en) * | 2019-11-20 | 2020-03-17 | 浙江大学 | Single-electrode implanted blood glucose sensor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Continuous monitoring of diabetes with an integrated microneedle biosensing device through 3D printing | |
US20130225956A1 (en) | Transdermal Sensor | |
CN104622480B (en) | Single needle integrated-type artificial pancreas | |
Velho et al. | In vivo calibration of a subcutaneous glucose sensor for determination of subcutaneous glucose kinetics | |
US20060263839A1 (en) | Combined drug delivery and analyte sensor apparatus | |
CN109406589B (en) | An implantable blood glucose test probe and its production method based on screen printing | |
JP5688971B2 (en) | Combination of sensor and infusion set using separation sites | |
US20080009763A1 (en) | Microprobe array structure and method for manufacturing the same | |
Jana et al. | Microneedle–Future prospect for efficient drug delivery in diabetes management | |
US20110028803A1 (en) | Method and device for non-invasive determination of the concentration of a substance in a body fluid | |
CN1606423A (en) | A minimally-invasive system and method for monitoring analyte levels | |
US20160166184A1 (en) | Microneedles and method of manufacture | |
CN110044986A (en) | Glucose monitoring probe | |
WO2018201931A1 (en) | Analyte monitoring and automatic medication delivery system | |
CN112710713A (en) | Implanted glucose monitoring probe | |
CN102920465A (en) | Glucose sensor | |
CN202974934U (en) | Glucose sensor | |
CN101716073A (en) | Invasive inclined needle skin-painless dry electrode device for recording electro-physiological signals for long term | |
CN106913347A (en) | Sensor base plate, analysis element, glucose assays and insulin feedway | |
CN110186976A (en) | Working electrode of glucose monitoring probe and manufacturing method thereof | |
WO2023134762A1 (en) | Microneedle patch for continuously monitoring or detecting in-vivo analyte, preparation method therefor, and related apparatus | |
CN113546294A (en) | A microneedle self-detection and treatment device | |
CN110051365A (en) | A kind of implanted electrode for continuing to monitor for a long time | |
CN114569124B (en) | Microneedle array enzyme composite electrode and preparation method thereof | |
CN209525297U (en) | A kind of implanted blood sugar test probe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190726 |